The Interleukin-2 Market is Set to Reach USD 4 Billion by 2034, Driven by IL-2 Targeting Fusion Proteins, Monoclonal antibodies, and Gene Therapies Across Immunology, Dermatology, Neurodegenerative Disorders, and Oncology | DelveInsight

DelveInsight Business Research, LLP United States of America United Kingdom Ireland

 
[phone]

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/the-interleukin-2-market-is-set-to-reach-usd-4-billion-by-2034-driven-by-il-2-targeting-fusion-proteins-monoclonal-antibodies-and-gene-therapies-across-immunology-dermatology-neurodegenerative-disorders-and-oncology---delve-302407749.html